Puma Biotechnology Inc. (PBYI)
NASDAQ · Healthcare
Puma Biotechnology Inc. Operating Income 2017–2025
Puma Biotechnology Inc. annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Puma Biotechnology Inc. operating income for the quarter ending March 31, 2026 was -3.8 M, a 196.08% decrease year-over-year.
- Puma Biotechnology Inc. operating income for the twelve months ending March 31, 2026 was 16.4 M, a 37.50% decrease year-over-year.
- Puma Biotechnology Inc. annual operating income for 2025 was 37.3 M, a 20.45% increase from 2024.
- Puma Biotechnology Inc. annual operating income for 2024 was 31.0 M, a 5.13% decrease from 2023.
- Puma Biotechnology Inc. annual operating income for 2023 was 32.6 M, a 37.61% increase from 2022.
- Puma Biotechnology Inc. annual operating income for 2022 was 23.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Puma Biotechnology Inc. Operating Income — FAQ
Puma Biotechnology Inc. (PBYI) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Puma Biotechnology Inc.'s operating income?
Puma Biotechnology Inc. (PBYI) reported operating income of $37M for fiscal 2025.
Where can I see PBYI's operating income history?
The chart and table above show Puma Biotechnology Inc.'s operating income by year and by quarter, including the growth rate.